Literature DB >> 29373458

Relationship Between the DSM-5 Anxious Distress Specifier and the Hamilton Depression Rating Scale Anxiety/Somatization Factor.

Mark Zimmerman1, Heather Clark, Patrick McGonigal, Lauren Harris, Carolina Guzman Holst, Jacob Martin.   

Abstract

We examined the association between the Hamilton Depression Scale (HAMD) approach to classifying depressed patients into anxious and nonanxious subgroups and the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) anxious distress specifier subtyping. Two hundred two depressed patients were interviewed with semistructured diagnostic interviews. Patients were rated on the 17-item HAMD and the Hamilton Anxiety Rating Scale and completed the Clinically Useful Anxiety Outcome Scale. Both approaches toward identifying anxiety in depressed patients resulted in most of the patients meeting the anxiety subtype. Both subtyping methods were significantly correlated with clinician-rated and self-report measures of anxiety, and scores on the anxiety scales were higher in the patients who met the anxious subtype. However, DSM-5 anxious distress subtyping was only marginally associated with the HAMD anxiety/somatization factor subtyping approach (k = 0.21), and dimensional scores were only moderately correlated (r = 0.50). These findings indicate that the DSM-5 and HAMD approaches toward identifying an anxious subtype of depression are not interchangeable.

Entities:  

Mesh:

Year:  2018        PMID: 29373458     DOI: 10.1097/NMD.0000000000000767

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  5 in total

1.  The effects of total enteral nutrition via nasal feeding and percutaneous radiologic gastrostomy in patients with dysphagia following a cerebral infarction.

Authors:  Tianwen Yuan; Guoqing Zeng; Qi Yang; Yang He; Peng Kong; Saibo Wang; Xing Zhou; Jun Cao
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity.

Authors:  Gavin J Lyndon; Rita Prieto; Dalia B Wajsbrot; Christer Allgulander; Borwin Bandelow
Journal:  Int Clin Psychopharmacol       Date:  2019-05       Impact factor: 1.659

3.  Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies.

Authors:  Michael E Thase; Emmanuelle Weiller; Peter Zhang; Catherine Weiss; Roger S McIntyre
Journal:  Neuropsychiatr Dis Treat       Date:  2018-12-20       Impact factor: 2.570

4.  Comparing the associations of three psychometric scales at baseline with long-term prognosis of depression over a 10-year period.

Authors:  Ching-I Hung; Chia-Yih Liu; Shih-Chieh Hsu; Ching-Hui Yang
Journal:  Int J Methods Psychiatr Res       Date:  2021-10-29       Impact factor: 4.035

5.  Neural correlates of anxious distress in depression: A neuroimaging study of reactivity to emotional faces and resting-state functional connectivity.

Authors:  Laura Nawijn; Richard Dinga; Moji Aghajani; Marie-José van Tol; Nic J A van der Wee; Andreas Wunder; Dick J Veltman; Brenda W H J Penninx
Journal:  Depress Anxiety       Date:  2022-05-10       Impact factor: 8.128

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.